Concourse Financial Group Securities, Inc. Provention Bio, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
BUY
$3.4 - $7.88 $1,360 - $3,152
400 New
400 $3,000
Q4 2021

Feb 07, 2022
BUY
$5.59 - $7.39 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$5.66 - $8.33 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$6.71 - $11.04 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$10.12 - $19.45 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$11.79 - $18.94 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$10.34 - $15.2 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$7.81 - $17.0 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020
BUY
$5.42 - $17.75 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020
BUY
$5.84 - $14.9 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019
BUY
$6.83 - $13.0 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019
BUY
$2.3 - $13.79 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019
BUY
$1.97 - $2.57 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019
BUY
$1.73 - $4.0 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018
BUY
$3.4 - $4.81 $0 - $0
0 New
0 $0

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email